Literature DB >> 29476365

Challenges in early diagnosis of Kawasaki disease in the pediatric emergency department: differentiation from adenoviral and invasive pneumococcal disease.

Lorna Stemberger Maric1,2, Neven Papic3, Mario Sestan4, Ivica Knezovic4, Goran Tesovic4,5.   

Abstract

Early recognition and distinction of Kawasaki disease (KD) from other febrile infectious diseases is one of the biggest challenges in pediatric emergency departments (PED). The aim of this study was to assess the utility of clinical findings and routinely used laboratory parameters for early discrimination between KD, invasive pneumococcal disease (IPD) and adenovirosis (AdV). A retrospective, cross-sectional study of children aged 3-36 months consecutively admitted to the PED and diagnosed with either KD (n = 110), AdV (n = 440) or IPD (n = 122) was conducted. At first presentation to the PED, 56.3% of KD patients had none or only one clinical criterion, 31% of patients with AdV and 11% with IPD had > 2 criteria. The levels of platelets (Plt), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were higher and white blood cells (WBC) significantly lower in KD than in IPD and AdV group. The WBC < 20 ×109/l showed a sensitivity of 80.9% and specificity of 79.7% in comparison to AdV. The ROC curve showed a significant, but low sensitivity for AST, ALT and Plt. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) did not show any significant diagnostic accuracy. Significant association between incomplete KD and rash, WBC < 20 ×109 and Plt > 400 ×109/L compared to AdV and conjuctivitis, rash and Plt > 400 × 109/L, was found. Due to the time delay and nonspecific early presentation, differentiating KD from IPD and AdV is challenging. Tools used for identification of patients at risk for severe bacterial infections in PED lack sensitivity for identification of KD cases. New biomarkers are warranted for distinction of KD from IPD or AdV.

Entities:  

Keywords:  Adenovirosis; Children; Inflammatory parameters; Invasive pneumococcal disease; Kawasaki disease

Mesh:

Year:  2018        PMID: 29476365     DOI: 10.1007/s00508-018-1324-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  29 in total

Review 1.  Kawasaki syndrome.

Authors:  W H Mason; M Takahashi
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

2.  Rising incidence of Kawasaki disease in England: analysis of hospital admission data.

Authors:  Anthony Harnden; Bernadette Alves; Aziz Sheikh
Journal:  BMJ       Date:  2002-06-15

3.  Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.

Authors:  Sunil J Ghelani; Craig Sable; Bernhard L Wiedermann; Christopher F Spurney
Journal:  Pediatr Cardiol       Date:  2012-02-15       Impact factor: 1.655

4.  Emergency department laboratory evaluations of fever without source in children aged 3 to 36 months.

Authors:  Alan E Simon; Susan L Lukacs; Pauline Mendola
Journal:  Pediatrics       Date:  2011-11-21       Impact factor: 7.124

5.  Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.

Authors:  J C Burns; W H Mason; M P Glode; S T Shulman; M E Melish; C Meissner; J Bastian; A S Beiser; H M Meyerson; J W Newburger
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

6.  Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.

Authors:  Lorna Stemberger Maric; Ivica Knezovic; Neven Papic; Branko Mise; Srdan Roglic; Leo Markovinovic; Goran Tesovic
Journal:  Rheumatol Int       Date:  2014-11-28       Impact factor: 2.631

7.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

8.  The clinical manifestations and risk factors of a delayed diagnosis of Kawasaki disease.

Authors:  Chien-Chang Juan; Betau Hwang; Pi-Chang Lee; Yu-Jan Lin; Jen-Chung Chien; Hsin-Yuan Lee; C C Laura Meng
Journal:  J Chin Med Assoc       Date:  2007-09       Impact factor: 2.743

9.  Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.

Authors:  Georgia Giannouli; Chryssa Tzoumaka-Bakoula; Ioannis Kopsidas; Paraskevi Papadogeorgou; George P Chrousos; Athanasios Michos
Journal:  Pediatr Cardiol       Date:  2013-03-06       Impact factor: 1.655

10.  Recognising Kawasaki disease in UK primary care: a descriptive study using the Clinical Practice Research Datalink.

Authors:  Abigail Moore; Anthony Harnden; Richard Mayon-White
Journal:  Br J Gen Pract       Date:  2014-08       Impact factor: 5.386

View more
  2 in total

1.  Combined IFN-β and PLT Detection Can Identify Kawasaki Disease Efficiently.

Authors:  Kan Huijuan; Dong Yaping; Wang Bo; Hou Miao; Qian Guanghui; Yan Wenhua
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

2.  Kawasaki Disease Presenting as Acute Acalculous Cholecystitis.

Authors:  Demis N Lipe; Lindsey C Bridges
Journal:  Clin Pract Cases Emerg Med       Date:  2019-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.